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INTRODUCTION {#resp13744-sec-0005}
============

Silicosis is a progressive, fibrotic, occupational lung disease, which results from inhalation of respirable crystalline silica (RCS).[1](#resp13744-bib-0001){ref-type="ref"}, [2](#resp13744-bib-0002){ref-type="ref"} Occupations traditionally associated with increased risk of silicosis include glass and pottery making, mining and quarrying, sandblasting and construction trades that generate silica dust through stone or concrete work.[3](#resp13744-bib-0003){ref-type="ref"} Silicosis in workers exposed to artificial quartz conglomerates containing high proportions of crystalline silica particles has been a topic of investigation in recent years.[4](#resp13744-bib-0004){ref-type="ref"}, [5](#resp13744-bib-0005){ref-type="ref"}, [6](#resp13744-bib-0006){ref-type="ref"}, [7](#resp13744-bib-0007){ref-type="ref"}, [8](#resp13744-bib-0008){ref-type="ref"}, [9](#resp13744-bib-0009){ref-type="ref"}

Artificial stone, also termed engineered, agglomerated or reconstituted stone or quartz conglomerate, is a relatively new, increasingly popular building material that is used primarily to fabricate kitchen and bathroom countertops.[10](#resp13744-bib-0010){ref-type="ref"}, [11](#resp13744-bib-0011){ref-type="ref"} Artificial stone is a composite of quartz, the major filler, and coloured glass, shells, metals or mirrors bound together by a polymer resin.[12](#resp13744-bib-0012){ref-type="ref"} Artificial stone became commercially available in 1986, and the first report of artificial stone‐associated silicosis caused by stonemasonry was published in Italy in 2010.[13](#resp13744-bib-0013){ref-type="ref"} Since then, increasing numbers of cases have been reported from Spain, Israel, Australia, Turkey and the USA.[4](#resp13744-bib-0004){ref-type="ref"}, [5](#resp13744-bib-0005){ref-type="ref"}, [6](#resp13744-bib-0006){ref-type="ref"}, [7](#resp13744-bib-0007){ref-type="ref"}, [8](#resp13744-bib-0008){ref-type="ref"}, [9](#resp13744-bib-0009){ref-type="ref"} Artificial stone has been available in China since the early 2000s, but no reports of artificial stone‐associated silicosis in China have been published. We recently noted a marked increase in the number of patients with artificial stone‐associated silicosis.

At 70--90%, the silica content of artificial stone is far higher than that of natural stone (approximately 3% in marble and 30% in granite).[4](#resp13744-bib-0004){ref-type="ref"}, [14](#resp13744-bib-0014){ref-type="ref"} Thus, the risk of exposure to artificial quartz conglomerates appears to be higher than that of exposure to natural stone dust, and the associated silicosis may differ significantly in its latency and clinical characteristics. To determine whether artificial stone‐associated silicosis differs from natural stone‐associated silicosis, we studied a series of patients with newly diagnosed silicosis who attended our hospital, including 18 who were exposed to artificial stone dust and 63 who were exposed to natural stone dust.

METHODS {#resp13744-sec-0006}
=======

Study cohort {#resp13744-sec-0007}
------------

From January to December 2018, 81 patients with newly diagnosed silicosis were sequentially recruited from the Department of Occupational Medicine and Toxicology, Beijing Chao‐Yang Hospital. All patients completed a standardized questionnaire to collect information on their occupational histories (Table [S1](#resp13744-supitem-0001){ref-type="supplementary-material"} in Supplementary Information). No workplace exposure monitoring data were available. All patients were diagnosed according to the criteria for pneumoconiosis of the 2011 International Labour Organization classification and the International Classification of HRCT for Occupational Environmental Respiratory Diseases (ICOERD).[15](#resp13744-bib-0015){ref-type="ref"}, [16](#resp13744-bib-0016){ref-type="ref"} The patients were divided into two groups: 18 with artificial stone‐associated silicosis and 63 with natural stone‐associated silicosis.

This work was conducted at Beijing Chao‐Yang Hospital with approval from the human research ethics committee of Beijing Chao‐Yang Hospital, Capital Medical University. Informed consent was documented in writing.

Pulmonary function tests {#resp13744-sec-0008}
------------------------

The pulmonary function examination was standardized according to the American Thoracic Society (ATS)/European Respiratory Society (ERS) recommendations and included spirometry, body plethysmography and the measurement of carbon monoxide transfer factor of the lungs utilizing the single‐breath method.[17](#resp13744-bib-0017){ref-type="ref"}

High‐resolution computed tomography {#resp13744-sec-0009}
-----------------------------------

High‐resolution computed tomography (HRCT) scans in patients were performed with 0.625‐mm sections, a 1‐s scan time and a 10‐mm interval in the apex base scans with inclusion of both lungs in the field of view.

Statistical analysis {#resp13744-sec-0010}
--------------------

The mean values for relevant patient characteristics and pulmonary function variables are expressed as mean ± SD. The Mann--Whitney U‐test was used to assess differences between the two groups, as appropriate. The distribution of radiological opacities was evaluated using the chi‐square test. A *P*‐value of \< 0.05 denotes statistical significance. All data were analysed with SPSS version 21.0 (IBM SPSS, Armonk, NY, USA).

RESULTS {#resp13744-sec-0011}
=======

Characteristics of the study population {#resp13744-sec-0012}
---------------------------------------

Table [1](#resp13744-tbl-0001){ref-type="table"} displays the relevant clinical and other characteristics of patients, stratified by type of silicosis. Patients with artificial stone‐associated silicosis were younger than patients with natural stone‐associated silicosis and had shorter exposure durations. The decision to place a patient on the waiting list for lung transplantation was made in accordance with a consensus document for selection of lung transplant candidates[18](#resp13744-bib-0018){ref-type="ref"} and a previous study.[19](#resp13744-bib-0019){ref-type="ref"} However, candidates in both groups failed to undergo lung transplantation within the study period for lack of medical insurance. During a follow‐up period of 6--12 months, five patients (27.8%) with artificial stone‐associated silicosis died. A higher incidence of spontaneous pneumothorax, lung transplant candidates and mortality was found in patients with artificial stone‐associated silicosis than in those with natural stone‐associated silicosis (all *P* \< 0.05).

###### 

Demographics and clinical characteristics of individuals with artificial stone‐associated versus natural stone‐associated silicosis

  Parameters                               Artificial stone‐associated silicosis   Natural stone‐associated silicosis  *P*‐value
  --------------------------------------- --------------------------------------- ------------------------------------ ----------------------------------------------------
  No. of patients                                           18                                     63                  
  Male, *n* (%)                                         18 (100.0)                             52 (82.5)               0.145
  Age, mean ± SD                                        36.1 ± 9.6                             52.8 ± 8.6              0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  Current or ex‐smoker, *n* (%)                          12 (66.7)                             43 (68.3)               0.950
  Years of exposure                                      6.1 ± 2.8                             14.1 ± 7.3              0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  Time from exposure to illness (years)                  6.4 ± 2.9                            29.3 ± 11.7              0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  Simple silicosis, *n* (%)                              4 (22.2)                              38 (60.3)               0.004[\*\*](#resp13744-note-0100){ref-type="fn"}
  Complicated silicosis, *n* (%)                         14 (77.8)                             25 (39.7)               0.004[\*\*](#resp13744-note-0100){ref-type="fn"}
  PFT at initial evaluation                                                                                            
  FVC (% predicted)                                     69.0 ± 29.5                           97.5 ± 16.0              0.004[\*\*](#resp13744-note-0100){ref-type="fn"}
  FEV~1~ (% predicted)                                  65.2 ± 29.4                           84.4 ± 19.4              0.049
  FEV~1~/FVC ratio (%)                                  80.7 ± 11.5                           71.6 ± 12.6              0.031[\*](#resp13744-note-0003){ref-type="fn"}
  TLC (% predicted)                                     68.0 ± 18.4                           96.0 ± 14.5              0.001[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  DL~CO~ (% predicted)                                  47.5 ± 22.2                           80.1 ± 18.6              0.001[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  CPI                                                   56.4 ± 27.4                           15.9 ± 13.9              0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  PaO~2~ (mm Hg)                                        64.8 ± 9.5                            88.2 ± 11.1              0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  Spontaneous pneumothorax, *n* (%)                      3 (16.7)                               1 (1.6)                0.033[\*](#resp13744-note-0003){ref-type="fn"}
  Lung transplant candidates, *n* (%)                    7 (38.9)                               2 (3.2)                0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}
  Mortality, *n* (%)                                     5 (27.8)                               0 (0.0)                0.000[\*\*\*](#resp13744-note-0101){ref-type="fn"}

*P* ≤ 0.05;

*P* ≤ 0.01;

*P* ≤ 0.001.

Data are presented as mean ± SD, unless otherwise stated.

CPI, composite physiological index; DL~CO~, diffusing capacity of the lung for carbon monoxide; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; PaO~2~, partial pressure of oxygen; PFT, pulmonary function test; TLC, total lung capacity.

Occupational dust exposure {#resp13744-sec-0013}
--------------------------

The 63 patients with natural stone‐associated silicosis were all local residents. Twenty‐nine patients had been exposed to silica dust in the processing of jade and 34 patients engaged in mining and quarrying. The jade‐processing factories were functional from the 1970s to the 1990s, and the mining plants had been open from the 1970s to the 2000s. These enterprises used lower level production technologies and occupational protection strategies. Eighteen patients (28.6%) with natural stone‐associated silicosis reported using disposable masks during all working hours, 27 (42.8%) reported using disposable masks 3--5 h per day during working hours and 18 (28.6%) reported working without any personal respiratory protection.

Of the 18 patients with artificial stone‐associated silicosis, 5 were from Fujian province, 4 from Guangdong province, 4 from Anhui province, 2 from Shanghai, 2 from Jiangsu province and 1 from Zhejiang province. Four patients (22.2%) from the same artificial stone factory reported using disposable masks during cutting, polishing and grinding activities and applying water curtains. Fourteen patients (77.8%) performed cutting and home installation of kitchen and bathroom countertops without any respiratory protection.

HRCT findings {#resp13744-sec-0014}
-------------

The patients were classified into groups with complicated or simple silicosis on the basis of disease extent, as determined by HRCT.[3](#resp13744-bib-0003){ref-type="ref"} Complicated silicosis, or accelerated silicosis with progressive massive fibrosis (PMF), was defined as the presence of a large opacity or coalescence larger than 1.5 cm in diameter.[20](#resp13744-bib-0020){ref-type="ref"}, [21](#resp13744-bib-0021){ref-type="ref"} On that basis, 14 patients (77.8%) exposed to artificial stone were diagnosed as having complicated silicosis (Table [1](#resp13744-tbl-0001){ref-type="table"}). The incidence of ground‐glass opacities (GGO), large opacities, emphysema and pulmonary artery widening was significantly higher in patients with artificial stone‐associated silicosis than in those with natural stone‐associated silicosis (all *P* \< 0.05). In contrast, the incidence of rounded opacities and mediastinal lymphadenopathy was significantly lower in patients with artificial stone‐associated silicosis (all *P* \< 0.05) (Table [2](#resp13744-tbl-0002){ref-type="table"}).

###### 

HRCT findings in patients with artificial stone‐associated versus natural stone‐associated silicosis

  HRCT findings                                     Artificial stone‐associated silicosis   Natural stone‐associated silicosis  *P*‐value
  ------------------------------------------------ --------------------------------------- ------------------------------------ ----------------------------------------------------
  No. of patients                                                    18                                     63                  
  Rounded opacities, *n* (%)                                      6 (33.3)                              59 (93.7)               0.000[\*\*\*](#resp13744-note-0103){ref-type="fn"}
  Irregular opacities, *n* (%)                                    5 (27.8)                              23 (36.5)               0.492
  Large opacities, *n* (%)                                        14 (77.8)                             25 (39.7)               0.004[\*\*](#resp13744-note-0102){ref-type="fn"}
  GGO, *n* (%)                                                    16 (88.9)                              8 (12.7)               0.000[\*\*\*](#resp13744-note-0103){ref-type="fn"}
  Emphysema, *n* (%)                                              10 (55.6)                             17 (27.0)               0.023[\*](#resp13744-note-0006){ref-type="fn"}
  Pleural abnormalities, *n* (%)                                  15 (83.3)                             41 (65.1)               0.139
  Mediastinal and hilar lymphadenopathy, *n* (%)                  11 (61.1)                              63 (100)               0.000[\*\*\*](#resp13744-note-0103){ref-type="fn"}
  Pulmonary artery widening, *n* (%)                              7 (38.9)                               4 (6.3)                0.002[\*\*](#resp13744-note-0102){ref-type="fn"}

*P* ≤ 0.05;

*P* ≤ 0.01;

*P* ≤ 0.001.

GGO, ground‐glass opacity; HRCT, high‐resolution computed tomography.

Well‐defined rounded opacity and mediastinal lymphadenopathy were more frequently identified in patients with natural stone‐associated silicosis, and during a follow‐up period of 6--12 months, no change was found in the size, density or distribution of the opacities on HRCT in the 63 patients with natural stone‐associated silicosis (Fig. [1](#resp13744-fig-0001){ref-type="fig"}A,B). Two patients with artificial stone‐associated silicosis had extensive faint ground‐glass nodules, similar to hypersensitivity pneumonia (Fig. [1](#resp13744-fig-0001){ref-type="fig"}C). Severe radiological abnormalities in 13 patients with artificial stone‐associated silicosis were characterized by bilateral upper lobe fibrosis and volume loss with bilateral patchy consolidation, indistinct boundaries and ground‐glass attenuation, consistent with PMF (Fig. [1](#resp13744-fig-0001){ref-type="fig"}D). In addition, during the follow‐up of 6--12 months, HRCT showed rapid radiological progression in 13 patients (72.2%) with artificial stone‐associated silicosis (Fig. [2](#resp13744-fig-0002){ref-type="fig"}).

![Chest high‐resolution computed tomography (HRCT) of four patients with differing findings. (A, B) Patients with natural stone‐associated silicosis. (C, D) Patients with artificial stone‐associated silicosis. (A) A 52‐year‐old man had been handling raw materials containing silica for 15 years. HRCT showed small, diffuse, well‐defined nodules in both lungs. (B) A 59‐year‐old man had been mining for 20 years. HRCT showed large well‐defined opacities with distinct borders surrounded by radiating lines. (C) A 22‐year‐old man had been cutting artificial stone 6 years. HRCT showed extensive centrilobular ground‐glass nodules, similar to those seen in hypersensitivity pneumonia. (D) A 25‐year‐old man had been cutting and polishing bathroom and kitchen countertops for 5 years. HRCT showed bilateral patchy consolidation, indistinct boundaries and ground‐glass attenuation, consistent with progressive massive fibrosis.](RESP-25-518-g001){#resp13744-fig-0001}

![A 37‐year‐old man had been cutting, polishing and home installing artificial stone for 4 years. high‐resolution computed tomography (HRCT) showed rapid radiological progression. (A) HRCT image showed patchy, irregular opacities of varying density. (B) HRCT showed a reduction in the volume of the lungs and features characteristic of progressive massive fibrosis 7 months later.](RESP-25-518-g002){#resp13744-fig-0002}

Changes in pulmonary function {#resp13744-sec-0015}
-----------------------------

Pulmonary function was tested again in four patients with artificial stone‐associated silicosis, and rapid deterioration in lung function was found over the follow‐up period of 6--12 months, with a decline in pre‐bronchodilator forced vital capacity (FVC) of 587 (210--960) mL/year and forced expiratory volume in 1 s (FEV~1~) of 625 (360--860) mL/year (Table [3](#resp13744-tbl-0003){ref-type="table"}). Nine patients underwent pulmonary function tests at the time of the initial diagnosis but did not undergo them again 6 months later, when they experienced severe respiratory distress.

###### 

Deterioration of lung function in patients with artificial stone‐associated silicosis

  Patient   Respiratory function (most recent)                                                                        Pre‐bronchodilator FVC decline (mL/year)   Pre‐bronchodilator FEV~1~ decline (mL/year)   Follow‐up (months)
  --------- -------------------------------------------------------------------------------------------------------- ------------------------------------------ --------------------------------------------- --------------------
  \(1\)     Restrictive defect (FVC: 76.7%), reduced gas transfer (DL~CO~: 68.3%)                                                       960                                          860                               6
  \(2\)     Mixed obstructive/restrictive defect (FEV~1~: 56.6%, FVC: 68.5%), reduced gas transfer (DL~CO~: 35.1%)                      210                                          360                               12
  \(3\)     Restrictive defect (FVC: 36.7%), reduced gas transfer (DL~CO~: 39.9%)                                                       670                                          780                               9
  \(4\)     Normal spirometry, reduced gas transfer (DL~CO~: 70.8%)                                                                     510                                          500                               10

DL~CO~, diffusing capacity of the lung for carbon monoxide; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity.

During the follow‐up period, pulmonary function in 51 patients with natural stone‐associated silicosis declined to a pre‐bronchodilator FVC of 94.7 (−210 to 320) mL/year and FEV~1~ of 84.3 (−80 to 300) mL/year (Tables [4](#resp13744-tbl-0004){ref-type="table"},[S2](#resp13744-supitem-0001){ref-type="supplementary-material"} in Supplementary Information).

###### 

Deterioration of lung function of individuals with artificial stone‐associated vs. natural stone‐associated silicosis

  Parameters                  Artificial stone‐associated silicosis   Natural stone‐associated silicosis                       *P*‐value
  -------------------------- --------------------------------------- ------------------------------------ ----------------------------------------------------
  No. of patients                               4                                     51                  
  FVC decline (mL/year)                 587 (210 to 960)                      94.7 (−210 to 320)           0.001[\*\*\*](#resp13744-note-0009){ref-type="fn"}
  FEV~1~ decline (mL/year)              625 (360 to 860)                      84.3 (−80 to 300)            0.001[\*\*\*](#resp13744-note-0009){ref-type="fn"}

*P* ≤ 0.001.

Data are presented as median (range).

FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity.

Particle analysis {#resp13744-sec-0016}
-----------------

Four artificial stone dust samples collected from one of the factories were analysed using X‐ray powder diffraction. All samples were found to have a high silica content of above 90%. The particles derived from the samples had a high proportion of small particles (diameter \< 5 μm), and some were even smaller than 2 μm (Table [S3](#resp13744-supitem-0001){ref-type="supplementary-material"} in Supplementary Information). No particle size data were available from the natural stone cases for comparison.

DISCUSSION {#resp13744-sec-0017}
==========

In the present study, we report an outbreak of accelerated silicosis caused by artificial stone dust, which is different from natural stone‐associated silicosis. All patients with artificial stone‐associated silicosis had performed cutting or polishing without adequate ventilation or respiratory protection, which inevitably leads to high‐level exposure to RCS.

In our cohort, the 18 patients diagnosed with artificial stone‐associated silicosis had a mean age of 36.1 ± 9.6 years, a median exposure time of 6.1 years and median duration of exposure to artificial stone‐associated dust prior to onset of symptoms of 6.4 years. This is significantly shorter than times reported for patients with chronic silicosis caused by exposure in other industries. Previous studies reported durations of occupational exposure to artificial stone‐derived silica of 4--10 years.[4](#resp13744-bib-0004){ref-type="ref"} The manifestations of artificial stone‐associated silicosis were nodular centrilobular GGO, indistinct boundaries, ground‐glass attenuation, a high prevalence of PMF and emphysema. These features differ from those of traditional silicosis nodules, which are usually well circumscribed, round and fairly uniform in size and density.[22](#resp13744-bib-0022){ref-type="ref"} In addition, some, but not all, patients with artificial stone‐associated silicosis had mediastinal lymphadenopathy. These HRCT imaging features suggest early‐stage silicosis. Rapid radiological progression occurred in 13 patients with artificial stone‐associated silicosis over a period of 6--12 months, while no change was found on HRCT in the size, density or distribution of the opacities in 63 patients with natural stone‐associated silicosis.

Respiratory function tests in patients with artificial stone‐associated silicosis primarily demonstrated restrictive defect patterns and reduced gas transfer, while the respiratory function of patients with natural stone‐associated silicosis mainly demonstrated obstructive ventilatory dysfunction. Four patients with artificial stone‐associated silicosis experienced rapid deterioration in lung function over the following 6--12 months, with declines in FVC and FEV~1~. In patients with natural stone‐associated silicosis, deterioration in FVC and FEV~1~ was slower. In addition, the composite physiological index (CPI)[23](#resp13744-bib-0023){ref-type="ref"} was significantly higher in patients with artificial stone‐associated silicosis than in those with natural stone‐associated silicosis. Fourteen of the 18 patients with artificial stone‐associated silicosis had complicated silicosis and 7 required lung transplantation. Our data suggest that exposure to artificial stone dust is more harmful to the lungs than exposure to natural stone dust.

A recent study reported that dry cutting artificial stone using a hand‐operated circular saw generated a high concentration of respirable silica dust (44 mg/m^3^ over a 30‐min sampling period); cutting artificial stone with a wet blade was reported to generate 4.9 mg/m^3^ concentration of respirable silica dust; the concentration decreased to 0.6 mg/m^3^ when a wet blade was used in combination with local exhaust ventilation.[14](#resp13744-bib-0014){ref-type="ref"} Particles derived from artificial stone dust have been reported to contain a very high proportion (94.0 ± 5.6%) of small particles (\<5 μm) and 4.3 ± 3.7% of particles with a diameter between 5 and 10 μm.[12](#resp13744-bib-0012){ref-type="ref"} Intratracheal instillation of ultrafine particles can lead to significantly more severe pulmonary inflammatory responses than instillation of larger particles.[24](#resp13744-bib-0024){ref-type="ref"}, [25](#resp13744-bib-0025){ref-type="ref"}, [26](#resp13744-bib-0026){ref-type="ref"} Accumulation of small particles has been negatively correlated with the single‐breath diffusing capacity of the lung for diffusing capacity of the lung for carbon monoxide (DL~CO~), FEV~1~ and FVC.[12](#resp13744-bib-0012){ref-type="ref"} In our study, particles derived from the samples we collected contained a very high proportion of small particles, accounting for the severe deterioration in lung function and poor outcomes of the patients with artificial stone‐associated silicosis.

Various publications have reported clusters of silicosis cases caused by exposure to artificial stone dust.[27](#resp13744-bib-0027){ref-type="ref"} In 2016, China reported 10 072 newly diagnosed patients with silicosis, among which 43.78% were concentrated in Sichuan, Hunan and Chongqing provinces and Beijing.[28](#resp13744-bib-0028){ref-type="ref"} However, to our knowledge, there have been no reports of artificial stone‐associated silicosis in China until now. The artificial stone industry in China began in the early 2000s, and is mainly localized in the Pearl River Delta and Yangtze River Delta. The cities of Zhongshan, Heshan and Foshan are the earliest and the largest production areas. The 18 patients we treated for artificial stone‐associated silicosis were mainly from these areas. There are currently insufficient epidemiological data on artificial stone‐associated silicosis in China; further investigation is required.

Our findings highlight the severity of silicosis associated with artificial stone. More cases are likely to occur unless effective preventive measures are taken and safety practices are enforced. Occupational dust control is one of the key preventative measures against silicosis. The US National Institute of Occupational Safety and Health (NIOSH) recommends limiting exposures to RCS is 0.05 mg/m^3^.[29](#resp13744-bib-0029){ref-type="ref"} Currently, the RCS exposure standard in China is 0.2 mg/m^3^ as an 8‐h time‐weighted average.[30](#resp13744-bib-0030){ref-type="ref"} We recommend strict enforcement in artificial stone production. It is important to frequently monitor RCS exposures to detect overexposures in a timely manner. Collective protective measures should be applied in artificial stone workshops, including both wet cutting and local exhaust ventilation. Workers should be made aware of the risk associated with fabricating and cutting artificial stone. Personal protective equipment such as a protective mask, goggles, gloves, special footwear and a helmet should be used while working. Occupational health surveillance should be conducted regularly to detect silicosis early and intervene to prevent progression by halting further exposure.[29](#resp13744-bib-0029){ref-type="ref"}

Several limitations of this study should be noted. First, our patients were recruited from a single medical centre and the incidence of artificial stone‐associated silicosis in other areas of China is as yet unknown. Second, the patients with artificial stone‐associated silicosis had been referred from various provinces to our medical centre because we specialize in occupational medicine; thus, there may have been a selection bias. Third, because the study period was recent, the follow‐up period was relatively short. Finally, monitoring of workplace exposure was not possible.

In conclusion, artificial stone‐associated silicosis is characterized by a shorter latency, rapid radiological progression and accelerated loss of lung function. More individuals who have been exposed to artificial stone dust are likely to be diagnosed as having accelerated silicosis. Urgent action is required to increase awareness of the risk of silicosis in the artificial stone fabrication industry, and measures to control dust levels and monitor and protect workers in this industry are needed.
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DL~CO~

:   diffusing capacity of the lung for carbon monoxide

FEV~1~

:   forced expiratory volume in 1 s
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PMF

:   progressive massive fibrosis

RCS

:   respirable crystalline silica
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